Fig. 2From: Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experienceKaplan-Meier estimates. a Progression-free survival (PFS). b Overall survival (OS)Back to article page